Xuezhu Wang

535 total citations
37 papers, 331 citations indexed

About

Xuezhu Wang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xuezhu Wang has authored 37 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Surgery. Recurrent topics in Xuezhu Wang's work include Peptidase Inhibition and Analysis (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Gut microbiota and health (3 papers). Xuezhu Wang is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Gut microbiota and health (3 papers). Xuezhu Wang collaborates with scholars based in China, United States and Austria. Xuezhu Wang's co-authors include Li Huo, Wenjia Zhu, Xiang Li, Shaobo Yao, Marcus Hacker, Yongchang Zheng, Yuejuan Cheng, Xinting Sang, Ru Jia and Chunmei Bai and has published in prestigious journals such as Advanced Science, Physics in Medicine and Biology and Medicine.

In The Last Decade

Xuezhu Wang

31 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuezhu Wang China 9 132 99 76 75 68 37 331
Sarah Theurer Germany 11 78 0.6× 68 0.7× 70 0.9× 62 0.8× 36 0.5× 46 317
Navin Niles Australia 12 126 1.0× 143 1.4× 67 0.9× 72 1.0× 39 0.6× 13 394
Stefanie Stepanow Germany 7 44 0.3× 83 0.8× 37 0.5× 132 1.8× 28 0.4× 11 351
Carla Gambale Italy 13 108 0.8× 128 1.3× 81 1.1× 64 0.9× 53 0.8× 35 437
Ofra Maimon Israel 8 122 0.9× 96 1.0× 119 1.6× 39 0.5× 22 0.3× 23 291
Maria Gebre‐Medhin Sweden 9 113 0.9× 68 0.7× 36 0.5× 80 1.1× 25 0.4× 18 371
Benjamin Chevalier France 8 63 0.5× 86 0.9× 39 0.5× 76 1.0× 24 0.4× 28 273
Kenji Koneri Japan 11 131 1.0× 133 1.3× 131 1.7× 126 1.7× 12 0.2× 42 382
Yuchen Jin China 13 83 0.6× 84 0.8× 51 0.7× 127 1.7× 84 1.2× 35 439

Countries citing papers authored by Xuezhu Wang

Since Specialization
Citations

This map shows the geographic impact of Xuezhu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhu Wang more than expected).

Fields of papers citing papers by Xuezhu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuezhu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhu Wang. The network helps show where Xuezhu Wang may publish in the future.

Co-authorship network of co-authors of Xuezhu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuezhu Wang. A scholar is included among the top collaborators of Xuezhu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuezhu Wang. Xuezhu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xuezhu, Liping Zuo, Jian Xu, et al.. (2025). Clonal Hematopoietic Mutations in Plasma Cell Disorders: Clinical Subgroups and Shared Pathogenesis. Genomics Proteomics & Bioinformatics. 23(2).
2.
Wang, Xuezhu, Kaini Shen, Yuke Zhang, et al.. (2025). Molecular Stratification of Light-Chain Cardiac Amyloidosis With 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic Precision. JACC. Cardiovascular imaging. 18(3). 323–336. 4 indexed citations
3.
Yang, Mo, Yixiang Li, Kaibin Shi, et al.. (2025). Single‐Cell Transcriptomes of Immune Cells from Multiple Compartments Redefine the Ontology of Myeloid Subtypes Post‐Stroke. Advanced Science. 12(13). e2408722–e2408722. 2 indexed citations
4.
Wang, Dingli, et al.. (2024). Effects and mechanisms of sciadonic acid on colonic transit function through regulating 5-HT4/cAMP/PKA/AQP4 signaling pathway in STC model mice. The Journal of Nutritional Biochemistry. 131. 109676–109676. 4 indexed citations
6.
Wang, Xuezhu, Xuemin Gao, Junmei Wang, et al.. (2024). Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations. Annals of Hematology. 103(8). 3229–3233. 1 indexed citations
7.
Guo, Rui, Wenbo Hu, Xuezhu Wang, et al.. (2024). Xie Zhuo Tiao Zhi formula ameliorates chronic alcohol-induced liver injury in mice. Frontiers in Pharmacology. 15. 1363131–1363131. 2 indexed citations
9.
10.
11.
Wang, Xuezhu, Jingnan Wang, Chengyan Dong, et al.. (2023). Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents. Journal of Hepatocellular Carcinoma. Volume 10. 587–598. 5 indexed citations
12.
Wang, Xuezhu, Yajuan Gao, Chao Ren, et al.. (2022). Feasibility of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac Amyloidosis. JACC. Cardiovascular imaging. 15(11). 1960–1970. 25 indexed citations
15.
Wang, Jingnan, Bowei Liu, Xuezhu Wang, et al.. (2021). Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function. BMC Medical Imaging. 21(1). 90–90. 11 indexed citations
16.
Ding, Jie, Yushi Zhang, Jin Wen, et al.. (2020). Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2656–2665. 59 indexed citations
17.
Xu, Weiyu, Xiaoqian Wu, Xuezhu Wang, et al.. (2020). <p>Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients with Gallbladder Carcinoma</p>. Cancer Management and Research. Volume 12. 3271–3283. 6 indexed citations
18.
Wang, Xuezhu, Jingnan Wang, Xu Yang, Haitao Zhao, & Li Huo. (2020). Pembrolizumab Exacerbates Thyroid Diseases Shown on FDG PET/CT. Clinical Nuclear Medicine. 45(12). 1010–1012. 3 indexed citations
19.
Zhu, Wenjia, Yuejuan Cheng, Xuezhu Wang, et al.. (2019). Head-to-Head Comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study. Journal of Nuclear Medicine. 61(6). 897–903. 59 indexed citations
20.
Wang, Xuezhu, et al.. (2019). Hepatic Angiomyolipoma Having FDG Uptake at the Similar Level of the Normal Liver Parenchyma. Clinical Nuclear Medicine. 44(7). 599–601. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026